Abstract
Purpose
Although long-term survival is similar between men and women, little is known about the short-term outcomes following breast cancer surgery in men. This study was performed to compare postoperative outcomes adjusted for background factors between men and women with breast cancer using a Japanese nationwide inpatient database.
Methods
This study included 2126 men and 363,468 women who underwent surgery for stage 0–III breast cancer from July 2010 to March 2017. We generated a 1:4 matched-pair cohort matched for age, institution, and fiscal year at admission. We then conducted multivariable regression analyses to compare postoperative complications, 30-day readmission, duration of anesthesia, length of hospitalization, and total hospitalization costs between the sexes.
Results
Men were older, more likely to have comorbidities and advanced cancer, and more likely to undergo total mastectomy and axillary dissection than women. There were no significant differences in postoperative complications between the sexes, but men showed a lower risk of 30-day readmission (odds ratio 0.74; 95% confidence interval [CI] 0.57–0.95), shorter duration of anesthesia (difference − 22.0 min; 95% CI − 2.1 to − 0.5), shorter length of hospitalization (difference − 1.3 days; 95% CI − 2.1 to − 0.5), and lower total hospitalization costs (difference − 506 US dollars; 95% CI − 668 to − 334) than women.
Conclusions
The matched-pair cohort analyses revealed no significant differences in postoperative complications between men and women with breast cancer. However, men showed better outcomes than women in terms of 30-day readmission, duration of anesthesia, length of hospitalization, and total hospitalization costs.
This is a preview of subscription content, access via your institution.
References
- 1.
Korde LA, Zujewski JA, Kamin L et al (2010) Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 28:2114–2122. https://doi.org/10.1200/JCO.2009.25.5729
- 2.
Hong JH, Ha KS, Jung YH et al (2016) Clinical features of male breast cancer: experiences from seven institutions over 20 years. Cancer Res Treat 48:1389–1398. https://doi.org/10.4143/crt.2015.410
- 3.
Cardoso F, Bartlett JMS, Slaets L et al (2018) Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Ann Oncol 29:405–417. https://doi.org/10.1093/annonc/mdx651
- 4.
Yadav S, Karam D, Bin Riaz I et al (2020) Male breast cancer in the United States: treatment patterns and prognostic factors in the 21st century. Cancer 126:26–36. https://doi.org/10.1002/cncr.32472
- 5.
Anderson WF, Althuis MD, Brinton LA, Devesa SS (2004) Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83:77–86. https://doi.org/10.1023/B:BREA.0000010701.08825.2d
- 6.
Miao H, Verkooijen HM, Chia KS et al (2011) Incidence and outcome of male breast cancer: an international population-based study. J Clin Oncol 29:4381–4386. https://doi.org/10.1200/JCO.2011.36.8902
- 7.
Scott-Conner CEH, Jochimsen PR, Menck HR et al (1999) An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 126:775–781. https://doi.org/10.1016/S0039-6060(99)70135-2
- 8.
Willsher PC, Leach IH, Ellis IO et al (1997) A comparison outcome of male breast cancer with female breast cancer. Am J Surg 173:185–188. https://doi.org/10.1016/S0002-9610(97)89592-X
- 9.
Weir J, Zhao YD, Herman T et al (2018) Clinicopathologic features and radiation therapy utilization in patients with male breast cancer: a National Cancer Database study. Breast Cancer Basic Clin Res 12:1178223418770687. https://doi.org/10.1177/1178223418770687
- 10.
Zaenger D, Rabatic BM, Dasher B et al (2016) Is breast conserving therapy a safe modality for early-stage male breast cancer? Clin Breast Cancer 16:101–104. https://doi.org/10.1016/j.clbc.2015.11.005
- 11.
Cloyd JM, Hernandez-Boussard T, Wapnir IL (2013) Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983–2009. Ann Surg Oncol 20:1545–1550. https://doi.org/10.1245/s10434-013-2918-5
- 12.
Cloyd JM, Hernandez-Boussard T, Wapnir IL (2013) Poor compliance with breast cancer treatment guidelines in men undergoing breast-conserving surgery. Breast Cancer Res Treat 139:177–182. https://doi.org/10.1007/s10549-013-2517-y
- 13.
Fogh S, Kachnic LA, Goldberg SI et al (2013) Localized therapy for male breast cancer: functional advantages with comparable outcomes using breast conservation. Clin Breast Cancer 13:344–349. https://doi.org/10.1016/j.clbc.2013.05.004
- 14.
Fentiman IS (2018) Surgical options for male breast cancer. Breast Cancer Res Treat 172:539–544. https://doi.org/10.1007/s10549-018-4952-2
- 15.
Yasunaga H (2019) Real world data in Japan: Chapter II The diagnosis procedure combination database. Ann Clin Epidemiol 1:76–79
- 16.
Yamana H, Moriwaki M, Horiguchi H et al (2017) Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol 27:476–482. https://doi.org/10.1016/j.je.2016.09.009
- 17.
Inokuchi M, Kutomi G, Kijima Y et al (2020) The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition. Breast Cancer 27:4–8. https://doi.org/10.1007/s12282-019-01030-w
- 18.
Charlson M, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
- 19.
Hennessy S, Bilker WB, Berlin JA et al (1999) Factors influencing the optimal control-to-case ratio in matched case-control studies. Am J Epidemiol 149:195–197. https://doi.org/10.1093/oxfordjournals.aje.a009786
- 20.
Hayashi N, Kumamaru H, Isozumi U et al (2020) Annual report of the Japanese Breast Cancer Registry for 2017. Breast Cancer 27:803–809. https://doi.org/10.1007/s12282-020-01139-3
- 21.
Bernstein-Mohlo R, Singer A, Laitman Y et al (2019) Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms. Breast Cancer Res Treat 176:165–170. https://doi.org/10.1007/s10549-019-05228-6
- 22.
Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480–1490. https://doi.org/10.1200/JCO.2002.20.6.1480
- 23.
Chow I, Hanwright PJ, Hansen NM et al (2015) Predictors of 30-day readmission after mastectomy: a multi-institutional analysis of 21,271 patients. Breast Dis 35:221–231. https://doi.org/10.3233/BD-150412
- 24.
Gannon CJ, Pasquale M, Tracy JK et al (2004) Male gender is associated with increased risk for postinjury pneumonia. Shock 21:410–414. https://doi.org/10.1097/00024382-200405000-00003
- 25.
Kollef MH, Von Harz B, Prentice D et al (1997) Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia. Chest 112:765–773. https://doi.org/10.1378/chest.112.3.765
- 26.
Sun SX, Leung AN, Dillon PW et al (2015) Length of stay and readmissions in mastectomy patients. Breast J 21:526–532. https://doi.org/10.1111/tbj.12442
- 27.
Landercasper J, Bennie B, Bray MS et al (2017) Does neoadjuvant chemotherapy affect morbidity, mortality, reoperations, or readmissions in patients undergoing lumpectomy or mastectomy for breast cancer? Gland Surg 6:14–26. https://doi.org/10.21037/gs.2016.08.04
- 28.
OECD (2020) Length of hospital stay (indicator). https://doi.org/10.1787/8dda6b7a-en. Accessed 07 Sept 2020
- 29.
Ogawa Y, Ikeda K, Watanabe C et al (2019) Super-elderly patient-specific perioperative complications in breast cancer surgery. Surg Today 49:843–849. https://doi.org/10.1007/s00595-019-01812-x
Funding
This work was supported by grants from the Ministry of Health, Labour and Welfare, Japan (19AA2007 and 20AA2005) and the Ministry of Education, Culture, Sports, Science and Technology, Japan (20H03907).
Author information
Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Study approval was obtained from the Institutional Review Board at The University of Tokyo.
Informed consent
The need for informed consent in the current study was waived because of the anonymous nature of the patient database.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Konishi, T., Fujiogi, M., Michihata, N. et al. Comparison of short-term surgical outcomes between men and women with breast cancer: a retrospective study using nationwide inpatient data in Japan. Breast Cancer Res Treat (2021). https://doi.org/10.1007/s10549-020-06069-4
Received:
Accepted:
Published:
Keywords
- Male breast cancer
- Mastectomy
- Postoperative outcomes
- Sex differences